Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening Practices for Breast and Nonbreast Cancers in High-Risk Mutation Carriers.

The Journal of surgical research - 1 Nov 2023

Coogan Alison C, Lunt Lilia G, Keshwani Sarah S, Sandhu Olivia, Zhang Yanyu, O'Donoghue Cristina, Madrigrano Andrea

Abstract excerpt

INTRODUCTION: Women with breast cancer often undergo genetic testing and may have a pathogenic variant associated with multiple cancers. This study examines the current screening practices for breast and nonbreast cancers in mutation carriers. METHODS: An institutional retrospective chart review of patients with BRCA1, BRCA2, ATM, CHEK2, BARD1, BRIP1, PALB2, and TP53 mutations were identified. Adherence to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Mutation

Source

Identifiers

PMID: 37516046
DOI: 10.1016/j.jss.2023.06.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening Practices for Breast and Nonbreast Cancers in High-Risk Mutation Carriers.PMID 37516046Read ↗

Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.Semantic proximity Read ↗

A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing.Semantic proximity Read ↗

EUS-based Pancreatic Cancer Surveillance in BRCA1/BRCA2/PALB2/ATM Carriers Without a Family History of Pancreatic Cancer.Semantic proximity Read ↗

Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptakeSemantic proximity Read ↗

Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic.Semantic proximity Read ↗

Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study.Semantic proximity Read ↗

Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic VariantsSemantic proximity Read ↗

BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management.Semantic proximity Read ↗

Breast cancer screening adherence after multigene panel testing among women with pathogenic variants in moderate-risk genes or with empirically increased breast cancer risk.Semantic proximity Read ↗

Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment.Semantic proximity Read ↗

Diagnosis, Management, and Surveillance for Patients With PALB2, CHEK2, and ATM Gene Mutations.Semantic proximity Read ↗

BRCA-associated pancreatico-biliary neoplasms: Four cases illustrating the emerging clinical impact of genotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.